# reload+after+2024-01-21 10:35:36.431346
address1§Chesterford Research Park
city§Little Chesterford
zip§CB10 1XL
country§United Kingdom
phone§44 1223 426 060
website§https://arecor.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
fullTimeEmployees§51
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Sarah Jennifer Howell Ph.D.', 'age': 46, 'title': 'CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 421000, 'exercisedValue': 51458, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susan Day Lowther FCMA', 'age': 63, 'title': 'CFO, Company Secretary & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 306000, 'exercisedValue': 154380, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jan  Jezek Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Gerring', 'title': 'Senior Vice President of Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Manjit  Rahelu Ph.D.', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§-0.187
priceToSalesTrailing12Months§15.997804
currency§GBp
forwardEps§-0.19
exchange§LSE
quoteType§EQUITY
shortName§ARECOR THERAPEUTICS PLC ORD GBP
longName§Arecor Therapeutics plc
firstTradeDateEpochUtc§1622703600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§3cde453d-55e7-3d2c-aa00-f09d73c9de43
messageBoardId§finmb_39396547
targetHighPrice§539.0
targetLowPrice§377.0
targetMeanPrice§458.0
targetMedianPrice§458.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§2.276
grossMargins§1.0
ebitdaMargins§-2.89287
trailingPegRatio§None
